Physician profile
James P Murphy
NPI 1184903031
$2,793.90
in general payments reported to CMS, 2019-2025
13 companies · $427 in 2025
The $427 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $306 · 2020: $295 · 2021: $472 · 2022: $152 · 2023: $741 · 2024: $400 · 2025: $427.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,431 · Entertainment: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,431.24 |
| Entertainment | $136.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $565.88 | 2020-2024 | Clareon, Hydrus Microstent |
| Allergan, INC. | $433.19 | 2019-2022 | |
| Tarsus Pharmaceuticals, INC. | $279.37 | 2024-2025 | Xdemvy |
| Sun Pharmaceutical Industries INC. | $271.20 | 2023-2024 | Cequa |
| Optos, INC. | $255.45 | 2021-2023 | Panoramic Ophthalmoscope, Oct Ophthalmoscope, Nfc-700 |
| Rxsight INC | $187.50 | 2023 | Rxsight Contact Lens, Rxsight Light Adjustable Lens (Rxlal), Rxsight Injector Cartridge |
| Biotissue Holdings INC. | $167.86 | 2025 | |
| Abbvie INC. | $152.33 | 2022-2023 | |
| Sight Sciences, INC. | $129.55 | 2025 | Tearcare System |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $114.84 | 2019 | |
| Glaukos Corporation | $102.11 | 2021 | |
| Novartis Pharmaceuticals Corporation | $68.66 | 2021 | |
| Shire North American Group INC | $65.96 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Murphy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.